Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Serum HCV-RNA for evaluation of interferon-readministration to the former non responders in chronic hepatitis C].

Nihon rinsho. Japanese journal of clinical medicine - 1 Jul 1994

Sata M, Tanikawa K

Abstract excerpt

We investigated the efficacy of retreatment with interferon in patients with chronic hepatitis C who were non responders to the initial interferon treatment. The results were as follows: 1) The effective rate was very low and 2 of the 16 responded to the 2nd treatment. 2) Serum HCV-RNA levels before retreatment with interferon were compared among the 4 responders and the 13 non responders to interferon and it was...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chronic Disease
Share to Genotype
Share to Hepacivirus

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Hepatitis C

Share to Interferons

Share to RNA, Viral

Share to Treatment Outcome

Source

Identifiers

PMID: 7521422

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Serum HCV-RNA for evaluation of interferon-readministration to the former non responders in chronic hepatitis C].PMID 7521422Read ↗

[Value of high-dose interferon-alpha in chronic viral hepatitis C patients non-responder to a 1st treatment. Pilot study prospective and randomized trial].Semantic proximity Read ↗

[Clinical study of retreatment of chronic hepatitis C with interferon (IFN) for non-complete responders on initial treatment].Semantic proximity Read ↗

[Interferon, ribavirin and amantadine in prior nonresponders to interferon and ribavirin therapy with chronic hepatitis C (genotype 1)].Semantic proximity Read ↗

[beta-Interferon therapy of chronic hepatitis HCV+, 1b genotype].Semantic proximity Read ↗

[Comparative evaluation of serum HCV RNA by Roche Monitor Assay. Versions 1.0 and 2.0; as a predictive marker of subsequent response to IFN therapy].Semantic proximity Read ↗

[A trial of new interferon therapy for the patients with chronic hepatitis C resistant to interferon therapy].Semantic proximity Read ↗

[The factors associated with viral relapse after interferon treatment in chronic hepatitis C patients].Semantic proximity Read ↗

Interferon retreatment in chronic hepatitis C: which patients to choose, and what schedule to use.Semantic proximity Read ↗

[Prognostic relevance of hepatitis C virus genotype for responsiveness to interferon-alpha].Semantic proximity Read ↗

Genotype, serum level of HCV-RNA and response to interferon-alpha treatment in patients with chronic hepatitis C.Semantic proximity Read ↗

[Study for relapse cases of chronic hepatitis C treated with interferon (IFN) and approach to more successful re-treatment of IFN].Semantic proximity Read ↗

Pegylated interferon alfa-2b plus ribavirin in the retreatment of interferon-ribavirin nonresponder patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.